DAGCO Inc’s Gilead Sciences GILD Stock Holding History

DAGCO Inc’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13	Closed	-$1.59K	–	370
2025 Q4	$1.59K	Hold	13	–	–	﹤0.01%	367
2025 Q3	$1.43K	Hold	13	–	–	﹤0.01%	351
2025 Q2	$1.41K	Hold	13	–	–	﹤0.01%	349
2025 Q1	$1.42K	Buy	+13	New	+$1.34K	﹤0.01%	341
2024 Q4	–	Sell	-12	Closed	-$1.05K	–	127
2024 Q3	$1.05K	Hold	12	–	–	﹤0.01%	212
2024 Q2	$848	Sell	12 -10	-45%	-$667	﹤0.01%	217
2024 Q1	$1.62K	Sell	22 -2,407	-99%	-$185K	﹤0.01%	211
2023 Q4	$197K	Buy	+2,429	New	+$189K	0.18%	59

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

DAGCO Inc's GILD Position: Q1 2026 in Review

DAGCO Inc sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 13 shares — an estimated $1.59K sold.

DAGCO Inc first reported a position in GILD in Q4 2023 and held it in 8 quarters. The position peaked at $197K in Q4 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

DAGCO Inc reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
DAGCO Inc sold 13 Gilead Sciences shares in Q1 2026, an estimated $1.59K.
DAGCO Inc first reported a position in Gilead Sciences in Q4 2023 and held it in 8 quarters.
DAGCO Inc's Gilead Sciences position peaked at $197K in Q4 2023.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on DAGCO Inc's 13F filing for Q1 2026, filed 20 Apr 2026.